TD Cowen analyst Marc Frahm raised the firm’s price target on Incyte (INCY) to $88 from $86 and keeps a Buy rating on the shares. The firm said ...

Citi lowered the firm’s price target on Incyte (INCY) to $88 from $97 and keeps a Buy rating on the shares. The company reported Q4 results, ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Shares of Incyte Corp. INCY slid 1.09% to $74.13 Friday, on what proved to be an all-around poor trading session for the ...

Bruker Corporation today announced the launch of the VERTEX NEO Platform today with its first product, the VERTEX NEO R. This ...

This article is sponsored by Incyte. Lisa was compensated for her time participating in the interview. For Lisa, life with nonsegmental vitiligo has been a roller coaster of emotions. Navigating ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a whirlwind tour of 18 events that could take place throughout 2025.

That’s why Dr. Lee is partnering with Incyte for the Moments of Clarity program, joining others living with eczema to share their stories about finding relief from their symptoms. Diagnosed when ...

To access the replay you will need the conference ID number 13751174. The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days. A global ...